MedPath

Efficacy and Safety of Hydrolyzed Ginseng Extract on Impaired Fasting Glucose

Not Applicable
Completed
Conditions
Hyperglycemia
Interventions
Dietary Supplement: HGE (hydrolyzed ginseng extract)
Dietary Supplement: Placebo
Registration Number
NCT01854164
Lead Sponsor
Chonbuk National University Hospital
Brief Summary

This study was conducted to investigate the effects of daily supplementation of hydrolyzed ginseng extract(HGE) on glycemic status in subjects with impaired fasting glucose(IFG).

Detailed Description

This study was a 8 weeks, randomized, double-blind, placebo-controlled trial. Twenty subjects were randomly divided into HGE or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age 20-70 years with fasting glucose 100~126 mg/dL
Exclusion Criteria
  • Abnormal lipid profile values
  • Acute/chronic inflammation
  • Treated with corticosteroid within past 4 weeks
  • Cardiovascular disease
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of disease that could interfere with the test products or impede their absorption
  • Participation in any other clinical trials within past 2 months
  • Renal disease
  • Abnormal hepatic function
  • Under hypolipidemic drugs therapy within past 3 months
  • Under antipsychotic drugs therapy within past 2 months
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • History of alcohol or substance abuse
  • Pregnancy or breast feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HGE(hydrolyzed ginseng extract)HGE (hydrolyzed ginseng extract)HGE capsules(2cap/d, 960mg/d) for 8 weeks.
PlaceboPlaceboPlacebo for 8 weeks
Primary Outcome Measures
NameTimeMethod
Changes of blood glucose during OGTT(oral glucose tolerance test)8 weeks

Changes of fasting and postprandial glucose during OGTT were assessed before(baseline) and after the intervention.

Secondary Outcome Measures
NameTimeMethod
Changes of blood insulin during OGTT.8 weeks

Changes of blood insulin during OGTT were assessed before(baseline) and after the intervention.

Changes of glycated albumin, fructosamine, and lipid profile8 weeks

Changes of glycated albumin, fructosamine, and lipid profile were assessed before(baseline) and after the intervention

Trial Locations

Locations (1)

Clinical Trial Center for Functional Foods, Chonbuk National University Hospital

🇰🇷

Jeonju, Jeollabuk-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath